MENLO THERAPEUTICS INC COMMON (MNLO) analyst actions
Rating and price-target actions on MNLO in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the MNLO overview →
No MNLO analyst action events in the measured window.
Nothing matched in the current window — the MNLO overview has every event we measure for this name.
Get an email when MNLO moves on news →Keep exploring
More MNLO: earnings → · SEC filings → · MNLO overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| SI-BONE, Inc. (SIBN) | 310 | +0.14% | 56% |
| Galectin Therapeutics Inc. (GALT) | 309 | 0.00% | 50% |
| Syros Pharmaceuticals, Inc. (SYRS) | 307 | +0.51% | 55% |
| Adverum Biotechnologies, Inc. (ADVM) | 306 | 0.00% | 49% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.